The Latest Breaking News from Clinical Trial

Wall Street looks bullish on Biogen’s (BIIB) prospects after the company’s success during the Phase 3 clinical trial of lecanemab. The drug could boost the company’s financials significantly as it could herald a new era for people with Alzheimer’s disease. Its bright growth prospects have earned it a Strong Buy…

A shipment of Ebola vaccine candidates set to be used in a clinical trial have arrived in Uganda, where an outbreak has infected 142 people and killed at least 56, health authorities said on Thursday.

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

Hunter residents at high risk of developing Alzheimer's Disease will be given access to a clinical trial involving a breakthrough drug that appears to slow the development of the disease.

This often fatal disease found in many African countries is painful and lengthy to treat. But a single oral dose proved incredibly effective in a clinical trial, raising hopes of eradication.

A new treatment to repair the damage the disease causes could be on the horizon, thanks to a ground-breaking study underway in Tasmania.

Lecanemab, a newly developed drug, has showed promising results in clinical trials among Alzheimer patients

Data supports claims that a new drug reduced cognitive and functional decline in Alzheimer's patients by 27 per cent in a clinical trial.

The latest deal follows a successful clinical trial with NHS Lanarkshire

At present, medics may sometimes give out antibiotics unnecessarily because it is not clear whether an infection is caused by bacteria

A new drug, QPX9003, developed by Monash University researchers, and offers some real hope to holding off a predicted 'superbug' catastrophe.